AKTS NASDAQ
Aktis Oncology, Inc.
1W: -1.9%
1M: -13.1%
3M: +1.2%
YTD: -14.6%
1Y: +15559.3%
3Y: +364.1%
5Y: +137.2%
$20.34
+1.22 (+6.38%)
Weekly Expected Move ±8.9%
$16
$18
$20
$21
$23
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$20M
Revenue
-33.1% YoY
$-149M
Net Income
-93.3% YoY
$-66M
Free Cash Flow
-36.4% YoY
79.8%
Gross Margin
-703.6%
Op. Margin
-567.9%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-1020.3%
ROA-136.0%
ROIC264.8%
Valuation
P/E-24.7
P/B2.2
EV/EBITDA-6.9
Leverage
Debt/Equity-0.93
Current Ratio0.44
Interest Cov.-105.0x
Quality Scores
Piotroski F3/9
Altman Z-11.92
Beneish M-8.27